Contact The Gross Law Firm by July 7, 2025 Deadline to Join Class Action Against West Pharmaceutical Services, Inc.(WST)

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of West Pharmaceutical Services, Inc. regarding a class action lawsuit alleging that the company made materially false and misleading statements during the class period from February 16, 2023, to February 12, 2025 [1]. Allegations - The complaint claims that West Pharmaceutical Services misrepresented its visibility into customer demand, attributing headwinds to temporary COVID-related product destocking while actually facing significant ongoing destocking in its high-margin HVP portfolio [1]. - It is alleged that the SmartDose device, which was marketed as a high-margin growth product, negatively impacted the company's profit margins due to operational inefficiencies [1]. - The margin pressures are said to have created risks of costly restructuring activities, including the company's exit from continuous glucose monitoring contracts with long-standing customers [1]. - As a result of these issues, the positive statements made by the defendants regarding the company's business, operations, and prospects were materially false or misleading [1]. Next Steps for Shareholders - Shareholders who purchased shares of WST during the specified timeframe are encouraged to register for the class action by July 7, 2025, to potentially become lead plaintiffs [2]. - Once registered, shareholders will be enrolled in a portfolio monitoring software to receive updates throughout the lifecycle of the case [2]. About the Law Firm - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting the rights of investors who have suffered losses due to deceit, fraud, and illegal business practices [3]. - The firm aims to ensure that companies adhere to responsible business practices and seeks recovery for investors affected by false or misleading statements that led to artificial inflation of stock prices [3].